QT
SLS icon

Quantbot Technologies’s SELLAS Life Sciences SLS Stock Holding History

Quantbot Technologies’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Buy
9,118
+7,069
+345% +$48.8K 0.01% 1394
2026
Q1 		$8.67K Buy
+2,049
New +$9.17K ﹤0.01% 1543
2025
Q3 		– Sell
-389
Closed -$852 – 2077
2025
Q2 		$852 Buy
+389
New +$597 ﹤0.01% 1581

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Quantbot Technologies's SLS Position: Q2 2026 in Review

Quantbot Technologies increased its SELLAS Life Sciences (SLS) stake by 345% in Q2 2026, buying an estimated $48.8K and bringing the position to 9,118 shares worth $135K. The position accounts for 0.01% of the portfolio, ranked #1394.

Quantbot Technologies first reported a position in SLS in Q2 2025 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Quantbot Technologies held 9,118 shares of SELLAS Life Sciences worth $135K as of Q2 2026.
  • Quantbot Technologies bought 7,069 SELLAS Life Sciences shares in Q2 2026, an estimated $48.8K.
  • SELLAS Life Sciences made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1394 holding.
  • Quantbot Technologies first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.